Phase II study of induction cisplatin and irinotecan followed by concurrent carboplatin, etoposide, and thoracic radiotherapy for limited stage small cell lung cancer: CALGB 30206

INTRODUCTION: We sought to determine the efficacy of using both irinotecan- and etoposide-containing regimens sequentially for patients with untreated limited stage small cell lung cancer (LS-SCLC). METHODS: Patients with untreated, measurable LS-SCLC, performance status 0–2, and adequate organ func...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Kelley, Michael J., Bogart, Jeffrey A., Hodgson, Lydia. D., Ansari, Rafat. H., Atkins, James N., Pang, Herbert, Green, Mark R., Vokes, Everett E.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3524334/
https://ncbi.nlm.nih.gov/pubmed/23196276
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/JTO.0b013e31827628e1
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak